IRIS Accounts Production v25.1.4.42 11593986 Board of Directors Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 'A' 1.00000 Ordinary 'B' 1.00000 30793 44756 33432 158057 49400 82508 14825 30793 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115939862023-09-30115939862024-09-30115939862023-10-012024-09-30115939862022-09-30115939862022-10-012023-09-30115939862023-09-3011593986ns15:EnglandWales2023-10-012024-09-3011593986ns14:PoundSterling2023-10-012024-09-3011593986ns10:Director12023-10-012024-09-3011593986ns10:Director22023-10-012024-09-3011593986ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3011593986ns10:SmallEntities2023-10-012024-09-3011593986ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3011593986ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3011593986ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3011593986ns10:FullAccounts2023-10-012024-09-3011593986ns10:OrdinaryShareClass22023-10-012024-09-3011593986ns10:OrdinaryShareClass32023-10-012024-09-3011593986ns10:Director2422023-09-3011593986ns10:Director2422022-09-3011593986ns10:Director2422023-10-012024-09-3011593986ns10:Director2422022-10-012023-09-3011593986ns10:Director2422024-09-3011593986ns10:Director2422023-09-3011593986ns10:RegisteredOffice2023-10-012024-09-3011593986ns5:CurrentFinancialInstruments2024-09-3011593986ns5:CurrentFinancialInstruments2023-09-3011593986ns5:Non-currentFinancialInstruments2024-09-3011593986ns5:Non-currentFinancialInstruments2023-09-3011593986ns5:ShareCapital2024-09-3011593986ns5:ShareCapital2023-09-3011593986ns5:RetainedEarningsAccumulatedLosses2024-09-3011593986ns5:RetainedEarningsAccumulatedLosses2023-09-3011593986ns5:MotorVehicles2023-10-012024-09-3011593986ns5:ComputerEquipment2023-10-012024-09-3011593986ns5:MotorVehicles2023-09-3011593986ns5:ComputerEquipment2023-09-3011593986ns5:MotorVehicles2024-09-3011593986ns5:ComputerEquipment2024-09-3011593986ns5:MotorVehicles2023-09-3011593986ns5:ComputerEquipment2023-09-3011593986ns5:CostValuation2023-09-3011593986ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3011593986ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3011593986ns5:DeferredTaxation2023-09-3011593986ns5:DeferredTaxation2023-10-012024-09-3011593986ns5:DeferredTaxation2024-09-3011593986ns10:OrdinaryShareClass22024-09-3011593986ns10:OrdinaryShareClass32024-09-30115939861ns10:Director12023-09-30115939861ns10:Director12022-09-30115939861ns10:Director12023-10-012024-09-30115939861ns10:Director12022-10-012023-09-30115939861ns10:Director12024-09-30115939861ns10:Director12023-09-30
REGISTERED NUMBER: 11593986 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

ASPIRE ORTHOPAEDICS LIMITED

ASPIRE ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 11593986)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ASPIRE ORTHOPAEDICS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: A R Chitre
Mrs E A H Chitre





REGISTERED OFFICE: Chandler House
7 Ferry Road Office Park
Riversway
Preston
Lancashire
PR2 2YH





REGISTERED NUMBER: 11593986 (England and Wales)





ACCOUNTANTS: Wallwork Nelson & Johnson
Chandler House
7 Ferry Road Office Park
Riversway
Preston
Lancashire
PR2 2YH

ASPIRE ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 11593986)

BALANCE SHEET
30 SEPTEMBER 2024

30/9/24 30/9/23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 33,359 41,059
Investments 5 5,150 5,150
38,509 46,209

CURRENT ASSETS
Debtors 6 26,033 37,795
Cash at bank and in hand 58,505 14,810
84,538 52,605
CREDITORS
Amounts falling due within one year 7 27,321 27,957
NET CURRENT ASSETS 57,217 24,648
TOTAL ASSETS LESS CURRENT
LIABILITIES

95,726

70,857

CREDITORS
Amounts falling due after more than one
year

8

(2,187

)

(3,437

)

PROVISIONS FOR LIABILITIES 9 (1,414 ) (1,819 )
NET ASSETS 92,125 65,601

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 92,025 65,501
SHAREHOLDERS' FUNDS 92,125 65,601

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ASPIRE ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 11593986)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 June 2025 and were signed on its behalf by:




A R Chitre - Director



Mrs E A H Chitre - Director


ASPIRE ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 11593986)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Aspire Orthopaedics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor vehicles - 20% on reducing balance
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 3 ) .

ASPIRE ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 11593986)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 October 2023 41,200 3,888 45,088
Additions - 1,088 1,088
At 30 September 2024 41,200 4,976 46,176
DEPRECIATION
At 1 October 2023 2,060 1,969 4,029
Charge for year 7,828 960 8,788
At 30 September 2024 9,888 2,929 12,817
NET BOOK VALUE
At 30 September 2024 31,312 2,047 33,359
At 30 September 2023 39,140 1,919 41,059

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 October 2023
and 30 September 2024 5,150
NET BOOK VALUE
At 30 September 2024 5,150
At 30 September 2023 5,150

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/9/24 30/9/23
£    £   
Other debtors 8,395 7,002
Directors' current accounts 14,825 30,793
Prepayments and accrued income 2,813 -
26,033 37,795

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/9/24 30/9/23
£    £   
Hire purchase contracts 1,250 1,250
Amounts owed to group undertakings 460 -
Tax 22,196 23,047
Other creditors 1,315 -
Accruals and deferred income 2,100 3,660
27,321 27,957

ASPIRE ORTHOPAEDICS LIMITED (REGISTERED NUMBER: 11593986)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30/9/24 30/9/23
£    £   
Hire purchase contracts 2,187 3,437

9. PROVISIONS FOR LIABILITIES
30/9/24 30/9/23
£    £   
Deferred tax 1,414 1,819

Deferred
tax
£   
Balance at 1 October 2023 1,819
Credit to Income Statement during year (405 )
Balance at 30 September 2024 1,414

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30/9/24 30/9/23
value: £    £   
55 Ordinary 'A' £1 55 55
45 Ordinary 'B' £1 45 45
100 100

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 September 2024 and 30 September 2023:

30/9/24 30/9/23
£    £   
A R Chitre and Mrs E A H Chitre
Balance outstanding at start of year 30,793 (44,756 )
Amounts advanced 33,432 158,057
Amounts repaid (49,400 ) (82,508 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 14,825 30,793